Navigation Links
Optimer Pharmaceuticals Reports Third Quarter 2012 Financial Results
Date:11/1/2012

JERSEY CITY, N.J., Nov. 1, 2012 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) today announced the Company's financial results for the quarter ended September 30, 2012.

(Logo: http://photos.prnewswire.com/prnh/20090413/LA97352LOGO)

Third Quarter 2012 Financial Highlights:

  • DIFICID® gross sales in the U.S. and Canada of $18.7 million and net sales of $16.0 million, represent increases of 3.9% and 4.9% over the second quarter, respectively
  • Estimated DIFICID ex-wholesaler and ex-specialty pharmacy treatments shipped in the third quarter to U.S. and Canadian purchasing customers, including hospitals, retail pharmacies and long-term care facilities, increased by approximately 7.2% compared to the second quarter
  • Contract revenues from collaborations, which include royalties and bulk pharmaceutical sales, were $1.9 million
  • Total revenues were $17.9 million
  • Cash, cash equivalents and short-term investments at September 30 totaled $98.2 million
  • Net loss for the third quarter was $26.8 million, or $0.56 per share
  • Financial Overview
    Total revenues for the three months ended September 30, 2012 and 2011 were $17.9 million and $11.1 million, respectively, an increase of $6.8 million.  In the three months ended September 30, 2012, we recognized $16.0 million of net product sales of DIFICID in the U.S. and Canada.  We recognize product sales of DIFICID upon delivery of product to our wholesalers and specialty pharmacies. In addition, we recognized $1.9 million in contract revenue under our collaborations with Astellas Pharmaceuticals Europe Ltd., Astellas Pharma, Inc. and Specialized Therapeutics Australia, Pty. Ltd.

    We reported a net loss for the third quarter of 2012 of $26.8 million, or $0.56 per share on both
    '/>"/>

    SOURCE Optimer Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Optimer Pharmaceuticals to Present at September 2012 Investor Conferences
    2. Optimer Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Growth Conference
    3. Optimer Pharmaceuticals Appoints Stephen Newman to Its Board of Directors
    4. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2012 Financial Results
    5. Optimer Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
    6. Optimer Pharmaceuticals and Specialised Therapeutics Australia Collaborate to Commercialize Fidaxomicin for Clostridium difficile Infection in Australia and New Zealand
    7. First sales of DIFICLIR™ by Astellas Pharma Europe triggers 10 Million Euro Milestone Payment to Optimer Pharmaceuticals
    8. Optimer Pharmaceuticals to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
    9. MAP Pharmaceuticals Reports Third Quarter of 2012 Financial Results
    10. Cumberland Pharmaceuticals Reports Third Quarter 2012 Financial Results
    11. AcelRx Pharmaceuticals to Hold Third Quarter 2012 Financial Results Conference Call and Webcast on November 6, 2012
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/23/2014)... 2014 FDNA présentera ... série de démonstrations personnelles   FDNA® ... de l,analyse de la dysmorphologie assistée par ... lors de la réunion ASHG 2014, qui se ... , en Californie. FDNA présentera la dernière ...
    (Date:9/23/2014)... , September 23, 2014 ... l,automobile, la santé, le ferroviaire ou encore ... connectées, donneront progressivement accès à leurs données. ... nombreux capteurs installés au cœur des voitures, ... plusieurs dizaines de milliards le nombre de ...
    (Date:9/23/2014)... ORLANDO, Fla. and DUBLIN ... Inc. (OTC-BB: TNIB) ("we" or the "Company"), a ... innovative therapies for autoimmune diseases in emerging nations, ... has approved our common stock for DTC,s Deposit ... Fast Automated Securities Transfer Service ("FAST") transfer agent ...
    Breaking Medicine Technology:FDNA exposera sa solution Face2Gene intégrée en ligne avec London Medical Databases (LMD) à l'ASHG 2014 2FDNA exposera sa solution Face2Gene intégrée en ligne avec London Medical Databases (LMD) à l'ASHG 2014 3Altran transforme le big data du monde industriel en nouveau business 2TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 2TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 3TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 4
    ... July 11, 2007 /PRNewswire/ -- Inspiration,Biopharmaceuticals today ... development of new, proprietary forms of,recombinant Factor ... The data,were highlighted in an oral presentation ... of the International Society on Thrombosis and,Haemostasis ...
    ... Study in American Heart Journal , ,WINNIPEG, ... a cardiovascular focused, biopharmaceutical company,today announced that the ... Tirofiban and Sirolimus-Eluting,Stent Versus Abciximab and Bare Metal ... the July edition of the Journal,of the American ...
    Cached Medicine Technology:Inspiration Biopharmaceuticals Presents Data From Hemophilia,Program at International Society On Thrombosis and Haemostasis,(ISTH) Annual Meeting 2Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 2Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 3Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 4Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 5
    (Date:9/23/2014)... By Kathleen Doheny ... -- For babies born at very low birth weights, breast ... to a potentially dangerous infection known as cytomegalovirus (CMV), a ... very low birth weight infants -- all of whom weighed ... mothers with a history of CMV infection, to see whether ...
    (Date:9/23/2014)... bringing with its advances promises of individualized genetic ... interventions. Genetic tests are already guiding treatments ... c virus (HPC), and emerging research is showing ... an individual,s susceptibility to addiction to a substance, ... there appear to be many benefits inherent in ...
    (Date:9/23/2014)... 23, 2014 What: Rutgers Presbyterian ... West Side that embodies the inclusion and diversity ... Scripture and the Ecological Crisis, a public lecture ... Professor Emerita of Old Testament at Louisville Presbyterian ... wisdom that lends insight into current ecological problems, ...
    (Date:9/23/2014)... already obese as teenagers could grow up to earn ... normal weight. So says Petter Lundborg of Lund University, ... Linneas University and Lund University, all in Sweden. The ... and the United States, and the results are published ... researchers analyzed large-scale data of 145,193 Swedish-born brothers who ...
    (Date:9/23/2014)... September 23, 2014 Trevera provides ... market. Included are Oracle Managed Services , ... supports all versions of Oracle E-Business Databases ... , Trevera has announced a significant enhancement ... need help with their software technology management, project ...
    Breaking Medicine News(10 mins):Health News:Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds 2Health News:Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds 3Health News:NYU-Mount Sinai Beth Israel study explores drug users' opinions on genetic testing 2Health News:Inhabiting Eden: Christians, Scripture, and the Ecological Crisis – Public Lecture to Discuss Faith-Based Environmentalism 2Health News:Note to young men: Fat doesn't pay 2Health News:Trevera, Inc adds Management Support to Services 2Health News:Trevera, Inc adds Management Support to Services 3
    ... Eye Research Institute (SERI) found that increasing the contrast ... enjoyable to the visually impaired. // ,The U.S. ... device to help millions suffering eye diseases. People who ... from macular degeneration, diabetic retinopathy and other causes of ...
    ... family and community medicine and colleagues developed the latest tool ... developed a tool which is called the Newest vital sign. ... based on an ice cream nutrition label. Based on the ... literacy can be calculated. , Then it is ...
    ... has been legalized in Canada the sex workers feel that the ... public for negotiating with their customers in public and does not ... rented flat.// The sex workers organization feels that the law will ... to brutality and killing, as they are not sure about the ...
    ... undergo a liver transplant at the St James's University Hospital in ... to take as long as 10 hours, in which half the ... ,Lennox developed chronic liver problems and jaundice within weeks after his ... a transplant appeared to be the only way of saving his ...
    ... San Diego have designed mice containing fully functional human nerve ... neurodegenerative diseases such as Parkinson's and Alzheimer's. // ... the neurons were formed in the brains of mice that ... embryos. ,Studies showed that the human stem ...
    ... The human brain can be manipulated to get relief from ... University in California. ,As many as eight patients were ... brains while performing // mental exercises. Standard therapy has ... possibilities can be opened through the results of the research. ...
    Cached Medicine News:Health News:Visually impaired prefer specially enhanced TV 2Health News:Visually impaired prefer specially enhanced TV 3Health News:Human neurons grown in the brains of mice 2
    ... AFX (Air Fluid eXchange) Lens ... designed for use in an ... its use as a primary ... low profile and sutureless design ...
    ... 30° Prism are designed for ... recommended for tractional retinal detachments ... retinal detachment. They can be ... other midperipheral laser applications. Direct ...
    ... High-Mag 1.5x is specifically designed ... in macular hole surgery, optic ... membrane removal, traditional macular edema ... magnification. This lens was developed ...
    ... Chalam Flat is designed for ... and induction of posterior vitreous ... for macula whole surgery, epiretinal ... tractional epiretinal membranes. Direct image ...
    Medicine Products: